Alcon, the global leader in eye care dedicated to helping people see brilliantly, and Aerie Pharmaceuticals, Inc., a pharmaceutical company focused on the discovery, development, manufacturing and commercialization of first-in-class ophthalmic therapies, today announced the companies have entered into a definitive merger agreement through which Alcon will acquire Aerie. This transaction affirms Alcon
